Sentences with phrase «other cancer therapies»

Other cancer therapies may be used in addition to surgery if the cancer has metastasized and become systemic.

CRI: What's the advantage of immunotherapy over other cancer therapies?

«These studies provide promising evidence that autophagy blockade can be achieved, and that combining autophagy inhibitors with other cancer therapies in very sick patients can be accomplished safely in most cases.

Kelley also worries about the fundamental complexity of vaccines, which makes it harder to achieve full medical potential than with other cancer therapies, he feels.

Disney said the precise binding of Targapremir - 18a to microRNA - 18a means a cancer drug that follows this strategy would be likely to kill prostate cancer cells without causing the broader side effects seen with many other cancer therapies.

Not exact matches

One setback for these therapies which use the body's immune system to fight cancers is that they are, at times, more effective in certain patient pools than others.

About Nohla Therapeutics Nohla Therapeutics is a leading developer of off - the shelf cell therapies for the treatment of cancer and other critical diseases.

«There's already fantastic therapies to overcome heart disease, cancer and every other neurological disease based on this idea of reprogramming the software,» Kurzweil said.

The Kamens claim the main thing that distinguishes their foundation from other brain tumor foundations is their focus on pediatric brain cancer specifically, as well as their close ties with pharmaceutical and biotech companies working in the fields of immunotherapy and target gene therapy.

BioNTech, which has around 700 employees at sites in Germany — more than any other unlisted biotech firm in Europe — is also working on other cancer - fighting technologies, including antibodies, cell therapies and small molecules.

Niraparib is closer than any other PARP inhibitor to receiving regulatory approval for ovarian cancer maintenance therapy.

Far more medical researchers are using our new understanding of genetics to finely tune cancer therapies or other treatments.

The premise is simple: you send cookies to 3 other food bloggers and get 3 dozen cookies from 3 different food bloggers in return... and best of all, we get to support Cookies For Kids» Cancer, a national non-profit organization that funds new therapies used to fight against pediatric cCancer, a national non-profit organization that funds new therapies used to fight against pediatric cancercancer!

Metallic conductivity and hydrophilicity of MXenes have established them as electrodes in rechargeable batteries and supercapacitors, as well as other applications, including photothermal cancer therapy, electromagnetic shielding, water purification and gas sensing.

Now, Emily has remained cancer - free for almost five years and her parents have created a foundation to help other patients access experimental cancer therapies.

RADIATION therapy to treat cancer is more effective in some people than others.

Researchers are currently testing pembrolizumab to determine if it has the same result in other cancers, as well as trying to combine pembrolizumab with other therapies.

«Urologists tend to prefer to forgo adjuvant radiation therapy, because they fear the side effects, and radiation oncologists tend to prefer offering adjuvant radiation therapy because they fear the risk of metastasis [cancer spreading to other sites in the body],» Showalter said.

More researchers joined the fray, keen to test CAR - T therapy in patients with other cancers.

The WHI hormone therapy trials assessed heart disease, breast cancer, stroke, blood clots, colorectal cancer, hip fractures and deaths from other causes in women who used the hormones versus those who took a placebo.

Now a University of Colorado Cancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer cells may have been pushed past an important tipping point that offers retinoic acid resisCancer Center study published online ahead of print in the journal Oncogene offers compelling evidence explaining this failure and offering a possible strategy for the use of retinoic acid or other retinoids against some breast cancers: Because early clinical trials are often offered to patients who have already tried other more established therapies, breast cancer cells may have been pushed past an important tipping point that offers retinoic acid resiscancer cells may have been pushed past an important tipping point that offers retinoic acid resistance.

But success could leave a lasting mark on cancer care, by helping hundreds of thousands of patients every year, far more than other genetically targeted therapies.

By combining this strategy with cancer cell - targeting materials, we should be able to develop a therapy for glioblastoma and other challenging cancers in the future.»

Glioblastoma is one of the most difficult cancers to treat — even after surgery and other therapies, it usually kills people within a year of diagnosis.

The Chinese trial will enrol patients who have metastatic non-small cell lung cancer and for whom chemotherapy, radiation therapy and other treatments have failed.

Because the CAR - T cells do not eradicate all cancer cells, the researchers think the immune therapy will need to be combined with other treatments.

«We believe our findings will help improve this therapy for lung, bladder and other cancers.»

The biological complexity of cancer and other diseases demands a more formidable arsenal of therapies than currently available.

However, along with this seemingly linear storyline in which retinoids block progesterone's promotion of CK5 + cells, previous work in the lab of CU Cancer Center investigator Peter Kabos, MD, and others shows that breast cancers treated with anti-estrogen drugs like tamoxifen or aromatase inhibitors show an increased population of CK5 + cells — it is as if these therapies remove the roadblock of estrogen - dependent cells, leaving CK5 + cells to proliferate.

The U.S. attorney's office in Indianapolis had alleged that Guoqing Cao and Shuyu Li, both naturalized U.S. citizens and senior biologists at Eli Lilly, passed research on tailored therapies for cancer and drugs to treat diabetes, obesity, and other metabolic disorders to Jiangsu Hengrui Medicine, a company in Lianyungang, China.

«It is anticipated that this novel compound will have significant efficacy in human melanomas and other cancers either as a stand - alone therapy or in combination with other targeted or immune - based therapies,» explained co-corresponding author Rhoda Alani, MD, the Herbert Mescon Chair of Dermatology at Boston University School of Medicine (BUSM).

«Researchers identify novel mechanism in combination drug therapy for acute myeloid leukemia, other cancers.»

Fear over potential cancer and other risks has fueled a dramatic decrease in the number of women using hormone replacement therapy over the past 15 years.

However, other research has suggested that the estrogen - like effects of isoflavones may reduce the effectiveness of endocrine therapies used to treat breast cancer.

The researchers believe there are other disease entities, aside from cancers, that may be significantly affected by targeted epigenetic therapies.

«It is expected that this study will lay the foundation for developing a new class of potent and effective cancer therapies and the development of reagents targeting epigenetic events in immune - mediated diseases as well as other epigenetically - influenced diseases,» said Alani, who also is chief of dermatology at Boston Medical Center.

CAR - T cell therapy is particularly exciting because it works well in people whose cancers haven't responded to other available treatments, says Renier Brentjens, an oncologist at Memorial Sloan Kettering Cancer Center in New York City.

For example, changes in certain genes could indicate that his cancer was more likely to respond to a particular drug, while other mutations might predict little benefit from a specific therapy.

Michael A. Johnson and colleagues at the University of Kansas wanted to investigate how carboplatin therapy — commonly given to patients with breast, bladder, colon and other cancers — affects dopamine and serotonin.

This therapy may also be used for other types of cancer.

The trial opens the door for new therapies for the thousands of people with leukemia and perhaps, down the road, the millions suffering from other cancers.

«Our research paves the way for future clinical trials that screen for AIM2 expression in colon cancer and possibly other cancers to identify patients who may potentially benefit from personalized anti-Akt therapy,» Wilson said.

Although other cancer - associated proteins have been successfully attacked with targeted therapies in recent years, the myc protein has continued to elude efforts to develop drugs that target it.

However, in the wake of fatalities from gene therapy and other technologies, as well as the potential for cancers associated with stem cell transplants, governments are understandably nervous about safety issues — not to mention the ethical maze of tinkering with fledgling life.

Following cancer therapy, the dominant cells may die first, and other cells that were originally not as fit may find themselves better able to compete for necessary space and nutrients and continue to grow and take over the tumor.

He also plans a multicenter / multinational study of patients with melanoma or other types of cancer, to examine the effect of long - term CPAP therapy on those also diagnosed with sleep apnea.

An oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.

«Considering that frequent amplification of MET accounts for resistance to therapies now in development and to poor prognosis, not only in ovarian cancer but in other cancers too, our findings pinpoint an important new signaling hub, involving the role of FER in MET activation.

«One criticism of the PARP drugs is they are not active in patients who have developed resistance to other therapies, but we found veliparib appears to be effective in some platinum - resistant patients with recurrent or persistent disease,» said Robert L. Coleman, MD, lead author of the study and professor and vice chair of clinical research at the University of Texas MD Anderson Cancer Center, Houston.

Identified via mammography and other screening technologies, DCIS is currently diagnosed annually in about 60,000 women in the U.S., and is generally treated similarly to other more advanced breast cancers with surgery and radiation therapy.